Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
about
Fecal Calprotectin Measured By Patients at Home Using Smartphones--A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease.Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease.Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease.Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort studyAccuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease.Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.Biomarkers in management of inflammatory bowel disease.Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease.Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.Usefulness of a rapid faecal calprotectin test to predict relapse in Crohn's disease patients on maintenance treatment with adalimumab.Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.Biomarkers of inflammatory bowel disease: ready for prime time?Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practiceFrom bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
P2860
Q33445756-E4D8F562-D7CF-4987-9485-9D3CDF45C7B8Q33646469-EA47DA8E-A209-40F2-A91F-E7C86BF378FFQ33695598-F12E0A26-AE82-4884-BC8E-AE89FE9AFC6AQ36449604-3ABB507B-C61B-4B39-B68A-95ADAECDB192Q37372542-15B19F44-5BA9-4934-A9B0-28B459125089Q38190411-5A33205F-12DE-47E0-869C-296A8532D63FQ38215501-7FB5AC7B-C074-408C-AC56-B5B75B69D763Q38219444-FAB2A0D3-C889-4287-B515-93F794F45A17Q38641380-9B7DFC6B-8F85-4F90-99C5-5DFC9DFFCE82Q38673082-740E4E69-69BE-4A06-9D4E-4DAE1DCF8C8BQ38742261-3ACE0E64-2CE7-49F7-B008-16A0FC1F7C57Q40038096-BCEBFCB4-0F6F-4DA0-9C47-279F6871CBD1Q40288099-6E52AAC0-B23E-430B-8C83-FCD483B40D9FQ47134738-171D8F17-FF12-480A-8917-7BED0665FBBDQ48120066-6BBEA6DF-A427-4557-9B69-36BB0768FFCAQ49126220-D9E14BFE-5CAD-4A77-A5B6-25E5D8B30BD1Q55078576-6BFA5F10-2E56-4BAE-B7F1-87B3BAD0C54EQ57063313-3A14292E-F1F8-430B-BECD-CB25B8F78575Q58760402-295B6F2E-2C4E-49F8-9B0C-8D0BE8739DC1
P2860
Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Faecal calprotectin: comparati ...... d an established ELISA method.
@en
type
label
Faecal calprotectin: comparati ...... d an established ELISA method.
@en
prefLabel
Faecal calprotectin: comparati ...... d an established ELISA method.
@en
P2093
P356
P1476
Faecal calprotectin: comparati ...... d an established ELISA method.
@en
P2093
Filip J Baert
Hilde J M Vanpoucke
Liselotte Coorevits
P304
P356
10.1515/CCLM-2012-0386
P577
2013-04-01T00:00:00Z